These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10444271)

  • 41. Increased serum levels of vascular endothelial growth factor in human crescentic glomerulonephritis.
    Nitta K; Uchida K; Kimata N; Honda K; Horita S; Hayashi T; Ishizuka T; Kobayashi H; Kawashima A; Yumura W; Nihei H
    Clin Nephrol; 1999 Aug; 52(2):76-82. PubMed ID: 10480217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
    van den Berg JG; van den Bergh Weerman MA; Assmann KJ; Weening JJ; Florquin S
    Kidney Int; 2004 Nov; 66(5):1901-6. PubMed ID: 15496161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide.
    Itaya H; Imaizumi T; Yoshida H; Koyama M; Suzuki S; Satoh K
    Thromb Haemost; 2001 Jan; 85(1):171-6. PubMed ID: 11204570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of interleukin-4 and soluble CD23 in hypersynthesis of immunoglobulins A and E in patients with IgA nephropathy.
    Yano N; Endoh M; Takemura F; Naka R; Kashem A; Nomoto Y; Sakai H
    Nephron; 1996; 72(1):44-51. PubMed ID: 8903860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)].
    Tsukada M; Honda K; Nitta K; Yumura W; Nihei H
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):681-8. PubMed ID: 14631763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
    Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production of interleukin 2 (IL-2) and responsiveness to IL-2 of peripheral blood lymphocytes in minimal change nephrotic syndrome.
    Dohi K; Morita H; Ogawa S; Hirayama T; Yamada H; Ishikawa H
    Jpn J Med; 1991; 30(5):396-401. PubMed ID: 1803038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?
    Bakker WW; van Luijk WH
    Pediatr Nephrol; 1989 Jul; 3(3):341-9. PubMed ID: 2702117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isoelectric focusing and selectivity index in IgA nephrotic syndrome.
    Woo KT; Lau YK; Wong KS; Lee GS; Chin YM; Chiang GS; Lim CH
    Nephron; 1994; 67(4):408-13. PubMed ID: 7969672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does electron microscopy change the view of the diagnosis of IgA nephropathy?
    Maixnerová D; Honsová E; Merta M; Reiterová J; Rysavá R; Tesar V; Obeidová H; Motan J
    Prague Med Rep; 2005; 106(3):283-90. PubMed ID: 16463586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease.
    Wei CL; Cheung W; Heng CK; Arty N; Chong SS; Lee BW; Puah KL; Yap HK
    Nephrol Dial Transplant; 2005 Apr; 20(4):728-34. PubMed ID: 15728267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in primary glomerular diseases.
    Dohi K; Yamada H; Takai M; Fujii Y; Ishikawa H
    Clin Nephrol; 1987 Jan; 27(1):11-4. PubMed ID: 3493102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.
    Yoshizawa N; Kusumi Y; Matsumoto K; Oshima S; Takeuchi A; Kawamura O; Kubota T; Kondo S; Niwa H
    Nephron; 1989; 51(3):370-6. PubMed ID: 2918948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
    Tsunehisa N; Takemura T; Inui T; Kamiya H
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy.
    Sakamoto-Ihara T; Suzuki Y; Kurusu A; Yamashita M; Horikoshi S; Tomino Y
    Inflamm Res; 2007 Oct; 56(10):421-7. PubMed ID: 18026699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy.
    Matsumoto K; Kanmatsuse K
    Am J Nephrol; 2001; 21(6):455-64. PubMed ID: 11799262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
    Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
    Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.